Key result
Genetically predicted BMI was associated with a 71% increased risk of dilated cardiomyopathy with an odds ratio of 1.71 (95% CI, 1.40–2.10; p = 1.91E-07).
Why the study?
Observational studies show correlations between obesity, lifestyle factors, and dilated cardiomyopathy, but whether these relationships are causal remains unclear.
Do genetically predicted higher BMI and unhealthy lifestyle factors increase the risk of dilated cardiomyopathy?
Do genetically predicted higher BMI and unhealthy lifestyle factors increase the risk of dilated cardiomyopathy?
Genetically predicted higher BMI and smoking initiation are causally associated with an increased risk of dilated cardiomyopathy, highlighting the importance of lifestyle management.
Background Observational studies have suggested strong correlations between obesity (as measured by body mass index [BMI]), lifestyle factors such as smoking, alcohol consumption, coffee intake, and insomnia, and dilated cardiomyopathy (DCM). However, the causal relationship between these factors and DCM remains unclear. Methods A two-sample Mendelian randomization analysis was performed to evaluate these associations. Genetic instruments significantly associated exposures (including BMI, smoking, alcohol consumption, coffee intake, and insomnia) at the genome-wide significance threshold ( p < 5 × 10⁻⁸) were selected from relevant genome-wide association studies. Summary-level data for DCM were obtained from the IEU Open GWAS project, comprising 1,444 cases and 353,937 controls. Results Genetically predicted BMI was positively associated with DCM (odds ratio [OR] per one standard deviation (SD) increase, 1.68; 95% confidence interval [CI], 1.4–2.1; p = 6.44 × 10 − 7 ). The OR for DCM was 31.86 (95% CI, 3.95–257.27; p = 0.001) for one SD increase in smoking. However, genetically predicted alcohol consumption, coffee intake, and insomnia were not significantly associated with the risk of DCM in our primary analysis. Conclusion Our findings suggest the potential causal links among BMI, smoking, and DCM, underscoring the importance of lifestyle interventions in managing DCM. This study also provides a foundation for future research aimed at identifying individuals highly at risk for DCM.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied Dilated cardiomyopathy (n=355,381). BMI vs. null was evaluated on Association between BMI and DCM (OR 1.71, 95% CI 1.40–2.10, p=1.91E-07). Genetically predicted BMI was associated with a 71% increased risk of dilated cardiomyopathy with an odds ratio of 1.71 (95% CI, 1.40–2.10; p = 1.91E-07).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: